Although neuropathic arthropathy of the foot and ankle joints in diabetes is well known, the involvement of the knee joint is rare. Then, the management, particularly the use of arthroplasty, is a matter of debate. We report a 51-year-old man with neuroarthropathic involvement of both knees related to the chronic pancreatitis treated by modified primary total knee arthroplasty components using augments and extension stems only on the tibial side. Our 5-year observations revealed that although the replacement surgery in neuroarthropathy is associated with high rate of complications, it is highly effective in avoiding progressive functional disability and durable.
Purpose: This study aimed to evaluate the efficacy of carboxymethylcellulose (Seprafilm®) for the prevention and treatment of arthrofibrosis in rabbit knees, as well as to investigate its underlying mechanisms of action against fibrosis and adhesion formation. Methods: Sixteen male New Zealand white rabbits were randomly divided into two groups: a control group and a treatment group that received Seprafilm® following surgically induced arthrofibrosis in the knee joint. Macroscopic and histological assessments were performed to evaluate adhesion, fibrosis, inflammation, and edema. Results: In the control group, macroscopic adhesion was severe in five rabbits (62.5%), moderate in two (25%), and minimal in one (12.5%). No macroscopic adhesion was observed in the Seprafilm® group. The mean adhesion score was 2.5 ± 0.75 in the control group versus 0 in the treatment group (p < 0.001). Histologically, five rabbits (62.5%) in the control group showed significant fibrosis, and three (37.5%) showed moderate fibrosis, whereas all rabbits in the Seprafilm® group exhibited only minimal fibrosis (p < 0.001). Conclusions: Seprafilm® was effective in reducing both macroscopic and histological signs of adhesion and fibrosis in a rabbit arthrofibrosis model. These findings suggest its potential as a preventive and therapeutic agent in managing arthrofibrosis.
Elderly patients are more prone to surgical risk regardless of the procedure. The overall mortality rate is expected to be high in this population. The aim of this study was to evaluate the survival rates of octogenarians who underwent knee arthroplasty procedures. Sixty-two knee arthroplasties were performed on 52 patients who were >80 years of age at the time of the operation between November 1996 and May 2014. The preoperative American Society of Anesthesiologists (ASA) classes were available for 45 procedures. The database of the Civil Registry Service was used to assess whether the patients were alive at the time of the study. If they were deceased, their dates of death were recorded. The five-, 10-, and 15-year survival rates of patients were determined. Thirty patients (57.69%) were alive and 22 (42.31%) were deceased at the time of analysis. Based on the 62 procedures, the mean age of the patients at the time of the operation was 82.56 ± 2.18 years. The mean time span between the operation and death of patients who passed away was 6.4 ± 4.66 years. The mean age of the patients who were alive at the time of the study was 86.63 ± 3.60 years. The mean time that had passed since the operation was 4.41 ± 2.9 years for living patients. Only one patient died during the first 90 days postoperatively. The one-year mortality rate was 4.84% (three patients). A Kaplan-Meier survival analysis revealed that the mean survival time of the patients was 6.4 years, and the median survival time was 5.6 years. The five-year survival rate was 59%, the 10-year rate was 19%, and the 15-year rate was 7%. Octogenarians benefitted from knee replacement longer than expected. Early mortality risks can be avoided with proper patient selection.